Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synageva BioPharma

1996 FOUNDED
M&A STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
14 FINANCING ROUNDS
1 INVESTMENTS
Description

Developer of medicines for rare diseases. The company's focus is on developing, delivering and commercializing products for rare diseases.

Formerly Known As
AviGenics
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 33 Hayden Avenue
  • Lexington, MA 02421
  • United States

Synageva BioPharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Synageva BioPharma‘s full profile, request access.

Request full access to PitchBook

Synageva BioPharma Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Santhera Pharmaceuticals Formerly VC-backed Pratteln, Switzerland 000 00000 0000 00000
0000000 0000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000000 00000
0000000 0000000000 Corporation San Diego, CA 00 00000 000000000 00000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000000 0000000 Formerly VC-backed Novato, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Synageva BioPharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 03-Nov-2011 000000000000000000 00000 Medical Supplies 0000 00000
To view this company’s complete investment and acquisition history, request access »

Synageva BioPharma Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Synageva BioPharma‘s full profile, request access.

Request full access to PitchBook

Synageva BioPharma Executive Team (15)

Name Title Board
Seat
Contact
Info
Thomas Tisch Director
Glen Williams Senior Vice President, Global Technical Operations
Michael Glynn Senior Vice President, Global Technical Operations
Sanj Patel Founder, President, Director & Chief Executive Officer
Carsten Boess Chief Financial Officer & Senior Vice President

4 Former Executives

You’re viewing 5 of 15 executives. Get the full list »